Cellebrite DI (NASDAQ:CLBT) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Cellebrite DI (NASDAQ:CLBT) issued its earnings results on Thursday. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.02, Briefing.com reports. Cellebrite DI had a positive return on equity of 220.14% and a negative net margin of 32.57%. The business had revenue of $89.60 million for the quarter, compared to analysts’ expectations of $85.34 million. During the same period in the previous year, the firm posted $0.03 EPS. The company’s quarterly revenue was up 25.8% on a year-over-year basis.

Cellebrite DI Price Performance

NASDAQ:CLBT opened at $11.10 on Friday. Cellebrite DI has a 12 month low of $5.45 and a 12 month high of $12.50. The company’s 50 day moving average is $11.11 and its 200-day moving average is $9.89.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CLBT shares. Bank of America boosted their price target on shares of Cellebrite DI from $12.00 to $13.00 and gave the company a “buy” rating in a report on Monday, April 1st. William Blair upgraded Cellebrite DI from a “market perform” rating to an “outperform” rating in a report on Wednesday, March 13th. JPMorgan Chase & Co. upped their price target on Cellebrite DI from $12.00 to $14.00 and gave the company an “overweight” rating in a research report on Friday. Lake Street Capital began coverage on Cellebrite DI in a research report on Friday, April 19th. They set a “buy” rating and a $13.00 price objective for the company. Finally, Needham & Company LLC increased their price target on shares of Cellebrite DI from $13.50 to $14.00 and gave the stock a “buy” rating in a research report on Friday. Six investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $13.17.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.